These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18196212

  • 1. New developments in understanding and treating neuroinflammation.
    Infante-Duarte C, Waiczies S, Wuerfel J, Zipp F.
    J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212
    [Abstract] [Full Text] [Related]

  • 2. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
    Zipp F, Aktas O.
    Trends Neurosci; 2006 Sep; 29(9):518-27. PubMed ID: 16879881
    [Abstract] [Full Text] [Related]

  • 3. Neuroimmunology - the past, present and future.
    Nutma E, Willison H, Martino G, Amor S.
    Clin Exp Immunol; 2019 Sep; 197(3):278-293. PubMed ID: 30768789
    [Abstract] [Full Text] [Related]

  • 4. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
    Bar-Or A, Rieckmann P, Traboulsee A, Yong VW.
    CNS Drugs; 2011 Sep 01; 25(9):783-99. PubMed ID: 21870889
    [Abstract] [Full Text] [Related]

  • 5. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
    Stadelmann C.
    Curr Opin Neurol; 2011 Jun 01; 24(3):224-9. PubMed ID: 21455066
    [Abstract] [Full Text] [Related]

  • 6. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD, Nave KA.
    Annu Rev Neurosci; 2008 Jun 01; 31():247-69. PubMed ID: 18558855
    [Abstract] [Full Text] [Related]

  • 7. Stop inflammation and you stop neurodegeneration in MS - YES.
    Yong HY, Yong VW.
    Mult Scler; 2017 Sep 01; 23(10):1320-1321. PubMed ID: 28463075
    [No Abstract] [Full Text] [Related]

  • 8. Stop inflammation and you stop neurodegeneration in MS - NO.
    Kalincik T.
    Mult Scler; 2017 Sep 01; 23(10):1321-1323. PubMed ID: 28463073
    [No Abstract] [Full Text] [Related]

  • 9. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA, Mills KH.
    Brain Behav Immun; 2012 Jan 01; 26(1):1-10. PubMed ID: 21664452
    [Abstract] [Full Text] [Related]

  • 10. The good and the bad of neuroinflammation in multiple sclerosis.
    Naegele M, Martin R.
    Handb Clin Neurol; 2014 Jan 01; 122():59-87. PubMed ID: 24507513
    [Abstract] [Full Text] [Related]

  • 11. Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.
    Bjelobaba I, Savic D, Lavrnja I.
    Curr Pharm Des; 2017 Jan 01; 23(5):693-730. PubMed ID: 27981909
    [Abstract] [Full Text] [Related]

  • 12. Neurodegenerative diseases: The immunological perspective.
    Molteni M, Rossetti C.
    J Neuroimmunol; 2017 Dec 15; 313():109-115. PubMed ID: 29153601
    [Abstract] [Full Text] [Related]

  • 13. Statins as potential therapeutic agents in neuroinflammatory disorders.
    Stüve O, Youssef S, Steinman L, Zamvil SS.
    Curr Opin Neurol; 2003 Jun 15; 16(3):393-401. PubMed ID: 12858078
    [Abstract] [Full Text] [Related]

  • 14. Disease-associated oligodendroglia: a putative nexus in neurodegeneration.
    Castelo-Branco G, Kukanja P, Guerreiro-Cacais AO, Rubio Rodríguez-Kirby LA.
    Trends Immunol; 2024 Oct 15; 45(10):750-759. PubMed ID: 39322475
    [Abstract] [Full Text] [Related]

  • 15. Endoplasmic reticulum stress and inflammation in the central nervous system.
    Sprenkle NT, Sims SG, Sánchez CL, Meares GP.
    Mol Neurodegener; 2017 May 25; 12(1):42. PubMed ID: 28545479
    [Abstract] [Full Text] [Related]

  • 16. ACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases.
    Toscano-Tejeida D, Ibarra A, Phillips-Farfán BV, Fuentes-Farías AL, Meléndez-Herrera E.
    Med Hypotheses; 2016 Mar 25; 88():38-45. PubMed ID: 26880635
    [Abstract] [Full Text] [Related]

  • 17. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB, Dziegielewska KM.
    Neuropathol Appl Neurobiol; 2009 Apr 25; 35(2):132-46. PubMed ID: 19077110
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells in brain diseases.
    Ludewig P, Gallizioli M, Urra X, Behr S, Brait VH, Gelderblom M, Magnus T, Planas AM.
    Biochim Biophys Acta; 2016 Mar 25; 1862(3):352-67. PubMed ID: 26569432
    [No Abstract] [Full Text] [Related]

  • 19. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
    Sommer A, Winner B, Prots I.
    Mol Neurodegener; 2017 Oct 27; 12(1):78. PubMed ID: 29078813
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.